Serum Sema7A is increased in patients with acute aortic dissection

CONCLUSIONS: Sema7A is highly expressed in patients with AAD. Sema7A might be a valuable biomarker for the early diagnosis of AAD and has the potential to differentiate AAD from AMI and PE.PMID:37698489 | DOI:10.1080/14737159.2023.2254693
Source: Expert Review of Molecular Diagnostics - Category: Laboratory Medicine Authors: Source Type: research